Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 4, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

February 28, 2030

Conditions
Heart Failure
Interventions
DEVICE

Transcatheter mitral valve replacement

The SATURN TS TMVR System will be implanted through a transcatheter approach in patients with symptomatic mitral regurgitation.

Trial Locations (3)

Unknown

RECRUITING

Tbilisi Heart and Vascular Clinic, Tbilisi

RECRUITING

Vilnius University Hospital Santaros Klinikos, Vilnius

RECRUITING

Warsaw Medical University, Warsaw

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Avania

INDUSTRY

lead

InnovHeart

INDUSTRY